[Innovation or pseudo-innovation: that is the question].
Unger
Thomas
T
Center for Cardiovascular Research (CCR)/Institut für Pharmakologie und Toxikologie, Charité-Universitätsmedizin, Berlin. thomas.unger@charite.de
D000959:Antihypertensive Agents / Q000191:economics*; D004059:Diffusion of Innovation; D004232:Diuretics / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs / Q000639:trends*; D004345:Drug Industry / Q000191:economics; D015507:Drugs, Investigational / Q000191:economics*; D019317:Evidence-Based Medicine / Q000191:economics; D005544:Forecasting; D005858:Germany; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D017410:Practice Guidelines as Topic; D012110:Reserpine / Q000191:economics / Q000627:therapeutic use; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D004232:Diuretics; D015507:Drugs, Investigational; D012110:Reserpine